Delhi/NCR:

Mohali:

Dehradun:

Bathinda:

Mumbai:

Nagpur:

Lucknow:

BRAIN ATTACK:

Directorship Details
As on 31st December 2024
  • Max Healthcare Institute Limited
  • Alembic Pharmaceuticals Limited
  • Elecon Engineering Company Limited
  • Shreno Engineering Limited
  • Incozen Therapeutics Private Limited
  • Alembic Global Holding SA
  • Alembic Pharmaceuticals Inc
  • Alembic Pharmaceuticals Australia Pty Limited
  • Alembic Pharmaceuticals Europe Limited
  • Alembic Pharmaceuticals Canada Limited
  • Alnova Pharmaceuticals SA
  • Rhizen Pharmaceuticals AG
  • Dahlia Therapeutics SA
  • Alembic Pharmaceuticals S.A de C.V
  • Viramya Packlight LLP
Academic Qualifications
  • Double Major in Economics and Industrial Management from the Carnegie Mellon University in Pittsburgh, USA
  • Master of Business Administration in International Management from Thunderbird, The American Graduate School of International Management
Directorship Details
As on 31st December 2024
  • Max Healthcare Institute Limited
  • Alembic Pharmaceuticals Limited
  • Elecon Engineering Company Limited
  • Shreno Engineering Limited
  • Incozen Therapeutics Private Limited
  • Alembic Global Holding SA
  • Alembic Pharmaceuticals Inc
  • Alembic Pharmaceuticals Australia Pty Limited
  • Alembic Pharmaceuticals Europe Limited
  • Alembic Pharmaceuticals Canada Limited
  • Alnova Pharmaceuticals SA
  • Rhizen Pharmaceuticals AG
  • Dahlia Therapeutics SA
  • Alembic Pharmaceuticals S.A de C.V
  • Viramya Packlight LLP
Notes
  • Does not have any family relationships with any directors of the Company;
  • Does not have any conflict of interest with the Company in terms of Code of Conduct for Board of Directors and Senior Management of the Company;
  • Does not have any order disqualifying him for appointment as a director passed by a court or tribunal, and the order is in force as per section 164 of the Companies Act, 2013.